Radiation Dermatitis Wound Care: Assessment and Management
Clinical guide to radiation dermatitis wound care — RTOG grading, dressing selection by grade, oncology coordination, and billing considerations.
Damon Ebanks
Medipyxis

Radiation Dermatitis Wound Care: Assessment and Management
Radiation dermatitis affects an estimated 85-95% of patients receiving external beam radiation therapy, making it one of the most common treatment-related skin injuries that wound care practitioners encounter. While most radiation skin reactions are mild and self-limiting, approximately 10-15% of patients develop severe reactions that require professional wound management — particularly patients receiving radiation to the head and neck, breast, perineum, or skin fold areas where friction and moisture compound the radiation injury.
For wound care practitioners, radiation dermatitis management requires understanding the unique biology of irradiated tissue, coordinating care with the oncology team, and selecting dressings that protect without interfering with radiation delivery.
RTOG Grading: Classifying Radiation Dermatitis Severity
The Radiation Therapy Oncology Group (RTOG) grading scale is the standard classification for acute radiation skin reactions. It provides a shared language between wound care practitioners and radiation oncologists and determines the level of intervention required.
RTOG Grade 0 — No Visible Skin Reaction
No treatment needed. The patient may report mild warmth or sensitivity in the treatment field.
RTOG Grade 1 — Faint or Dull Erythema
- Appearance: Pink or faint redness, mild edema, possible dry desquamation (dry, flaky skin), mild epilation
- Patient experience: Itching, tightness, sensitivity similar to a mild sunburn
- Management: Gentle skin care — fragrance-free moisturizer applied to the treatment field (avoid applying within 1 hour of radiation treatment per most institutional protocols), loose-fitting cotton clothing, mild cleansing with lukewarm water
RTOG Grade 2 — Moderate to Brisk Erythema, Patchy Moist Desquamation
- Appearance: Bright red erythema, areas of moist desquamation (weeping, denuded skin) typically in skin folds, moderate edema
- Patient experience: Pain, burning, significant discomfort with clothing contact
- Management: This is where wound care intervention typically begins. Moist wound healing principles apply — protect the denuded areas, manage exudate, prevent infection, and maintain comfort
RTOG Grade 3 — Confluent Moist Desquamation, Pitting Edema
- Appearance: Large confluent areas of moist desquamation extending beyond skin folds, marked edema, possible hemorrhagic crusting
- Patient experience: Severe pain, inability to tolerate clothing or pressure, may affect daily function and sleep
- Management: Active wound management required. This grade may trigger a radiation treatment break, which the oncology team decides
RTOG Grade 4 — Ulceration, Hemorrhage, Necrosis
- Appearance: Full-thickness tissue loss, necrosis, hemorrhage
- Patient experience: Severe pain, risk of secondary infection, significant quality of life impact
- Management: Urgent wound management, likely radiation treatment interruption, multidisciplinary coordination required
Radiation Dermatitis Dressing Selection by Grade
Dressing selection for radiation dermatitis must balance wound care principles with radiation treatment logistics. Key constraints:
- Dressings must be removed before each radiation treatment (unless cleared by the radiation oncologist)
- Dressings with metal components (some silver dressings) can cause bolus effect — increasing radiation dose at the skin surface
- Adhesive dressings can cause further skin trauma on removal in already-compromised tissue
Grade 1 — Dry Desquamation
- Primary approach: Moisturizer only (no dressing needed)
- Products: Water-based, fragrance-free moisturizers; aloe vera gel (evidence limited but widely used); calendula-based creams (some evidence of benefit for breast radiation)
- Avoid: Petroleum-based products before radiation treatment (controversial — check institutional protocol), products containing alcohol or fragrances
Grade 2 — Patchy Moist Desquamation
- Primary dressing: Silicone foam dressings (Mepilex Lite, Mepilex Border Lite) — the most studied dressing for radiation dermatitis
- Alternative: Hydrogel sheets for comfort and cooling
- Rationale: Silicone adhesive minimizes skin stripping on removal; foam absorbs exudate while maintaining moisture balance; thin profile allows comfortable wear between treatments
- Application: Apply after radiation treatment, remove before next treatment (or leave in place if radiation team approves — some institutions allow Mepilex to remain in place during treatment)
For broader dressing selection principles including exudate management, see our wound care moisture balance guide.
Grade 3 — Confluent Moist Desquamation
- Primary dressing: Silver-free foam or hydrofiber dressings (check for metal content before using any silver dressing in the radiation field)
- For heavily exudative areas: Alginate covered with foam secondary dressing
- For pain management: Hydrogel sheets or medical-grade honey dressings
- Wound bed management: Gentle irrigation with normal saline — no aggressive cleansing or debridement without oncology team coordination
Grade 4 — Ulceration and Necrosis
- Wound management: Standard wound care principles apply — debridement (with oncology clearance), exudate management, infection control
- Radiation likely interrupted: The treatment plan is now a multidisciplinary decision
- Monitor for: Superinfection, hemorrhage, necrosis extension
Coordination with the Oncology Team
Radiation dermatitis management is inherently collaborative. The wound care practitioner manages the skin injury; the radiation oncologist manages the cancer treatment. Key coordination points:
Communication Essentials
- Inform the radiation team of the RTOG grade at each wound care visit and any changes since the last assessment
- Ask before debriding — some tissue that appears necrotic may be radiation-induced change that the oncology team wants to monitor, not remove
- Confirm dressing compatibility — ask whether the planned dressing can remain in place during treatment or must be removed
- Report infection signs promptly — radiation-compromised tissue is immunologically impaired and infections can escalate rapidly
- Document treatment breaks — if the radiation team pauses treatment due to skin reaction severity, document this in the wound care record with the reason and expected duration
Treatment Timelines
Acute radiation dermatitis typically:
- Begins 2-3 weeks after radiation initiation
- Peaks 1-2 weeks after radiation completion
- Resolves 2-4 weeks after completion (Grade 1-2) or 4-8+ weeks (Grade 3-4)
Late radiation effects (months to years after treatment) include chronic dry skin, telangiectasia, fibrosis, and radiation-induced ulceration. These late effects represent a different clinical entity — chronic radiation tissue injury — that may benefit from hyperbaric oxygen therapy.
Billing Considerations for Radiation Dermatitis Wound Care
Wound care visits for radiation dermatitis are billable when the severity warrants professional intervention (generally RTOG Grade 2+). For CPT code references applicable to wound care procedures including debridement and dressing application, see our wound care CPT codes 2026 guide.
Documentation for Coverage
- Document the RTOG grade and the clinical findings that support it
- Document why the skin reaction requires professional wound management (severity, location, patient inability to self-manage)
- Document coordination with the oncology team
- Link the wound care to the underlying diagnosis: radiation dermatitis secondary to radiation therapy for [primary cancer diagnosis]
- ICD-10 coding: L58.0 (acute radiodermatitis), L58.1 (chronic radiodermatitis), L58.9 (radiodermatitis, unspecified) — code the primary cancer diagnosis as the secondary code
Billing Nuances
- E/M services are billable for wound assessment and care planning
- Debridement codes (97597-97598) apply when debridement is performed on moist desquamation areas
- Application of topical wound care products is typically bundled into the E/M or debridement service
- If the wound care practitioner is not part of the radiation oncology practice, separate billing is straightforward; if co-located, check for billing compliance with the anti-markup rule
Key Takeaways
- 85-95% of radiation therapy patients develop some degree of dermatitis — wound care intervention is typically warranted at RTOG Grade 2 (patchy moist desquamation) and above
- Silicone foam dressings are the most studied dressing type for radiation dermatitis — they minimize skin stripping on removal, manage exudate, and some institutions allow them to remain in place during treatment
- Avoid metal-containing dressings in the radiation field — silver and other metallic components can cause bolus effect and increase radiation dose to the skin surface
- Coordination with the radiation oncology team is mandatory — confirm dressing compatibility, obtain clearance before debridement, and report RTOG grade changes promptly
- Document RTOG grade, oncology coordination, and medical necessity at every visit — link the wound care to the underlying cancer diagnosis and radiation treatment for proper coding and coverage